What if the biggest breakthrough in fertility care for millions of couples in Asia isn’t AI, but a simple, clinically validated technology that makes IVF-level outcomes finally affordable for the middle class?

In this episode of FemTech at Work, we sit down with Yve Lyppens, founder of Eve Fertility, to explore a bold vision: bringing IVF-like results to lower and middle-income couples across APAC at a fraction of today’s cost. Drawing on 15 years in medtech and 5 years in IVF and infertility, Yve explains how intra-vaginal culture (IVC) uses the woman’s body as a natural incubator instead of an expensive lab, making fertility treatment more accessible without compromising clinical pregnancy rates.

If you’re interested in FemTech, fertility, emerging markets, or mission-driven innovation, this conversation offers a rare, on-the-ground ...